BC
Brinker Capital Portfolio holdings
AUM
$3.13B
Turnover
16.67%
1-Year Est. Return
9.04%
This Fund
S&P 500
This Quarter
Est. Return
+21.71%
1 Year Est. Return
+9.04%
3 Year Est. Return
+36.1%
5 Year Est. Return
+56.66%
10 Year Est. Return
–
AUM
$3.13B
AUM Growth
+$624M
(+25%)
Cap. Flow
+$133M
Cap. Flow
% of AUM
4.25%
Top 10 Holdings %
Top 10 Hldgs %
23.47%
Holding
1,002
New
95
Increased
529
Reduced
305
Closed
72
Avg Time Held
2.3
years
Top 10 Avg Time Held
2.1
years
Top 20 Avg Time Held
2.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$15.2M |
| 2 |
iShares MBS ETF
MBB
|
+$13.9M |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$9.82M |
| 4 |
Invesco Preferred ETF
PGX
|
+$8.16M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$29.5M |
| 2 |
iShares Intermediate Government/Credit Bond ETF
GVI
|
+$14.6M |
| 3 |
Booking.com
BKNG
|
+$7.56M |
| 4 |
TJX Companies
TJX
|
+$6.46M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$5.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.66% |
| 2 | Technology | 15.39% |
| 3 | Healthcare | 11.95% |
| 4 | Financials | 8.26% |
| 5 | Industrials | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
601
Charles River Laboratories
CRL
$14.4B
| $723K | 0.02% |
+4,148
| New | +$662K |
2020 Q2
0 quarters
|
|
602
Ross Stores
ROST
$73.7B
| $721K | 0.02% |
8,453
-2,240
| -21% | -$203K |
2016 Q2
16 quarters
|
|
603
Otis Worldwide
OTIS
$26.3B
| $719K | 0.02% |
+12,640
| New | +$655K |
2020 Q2
0 quarters
|
|
604
Mitsubishi UFJ Financial
MUFG
$246B
| $716K | 0.02% |
182,093
-3,747
| -2% | -$14.8K |
2017 Q2
12 quarters
|
|
605
Fabrinet
FN
$14.1B
| $715K | 0.02% |
11,453
+4,597
| +67% | +$282K |
2020 Q1
1 quarter
|
|
606
Crane NXT
CXT
$3.04B
| $713K | 0.02% |
34,531
-13,246
| -28% | -$248K |
2017 Q3
11 quarters
|
|
607
Applied Materials
AMAT
$354B
| $710K | 0.02% |
11,753
+639
| +6% | +$34.5K |
2017 Q4
10 quarters
|
|
608
DELISTED
bluebird bio
BLUE
| $708K | 0.02% |
896
-13
| -1% | -$9.8K |
2018 Q4
6 quarters
|
|
609
Crown Holdings
CCK
$12.1B
| $707K | 0.02% |
10,858
+951
| +10% | +$59.8K |
2017 Q3
11 quarters
|
|
610
Sociedad Química y Minera de Chile
SQM
$17.6B
| $704K | 0.02% |
26,920
+9,698
| +56% | +$233K |
2020 Q1
1 quarter
|
|
611
AMN Healthcare
AMN
$1.46B
| $700K | 0.02% |
15,473
+3,762
| +32% | +$180K |
2017 Q1
13 quarters
|
|
612
Commercial Metals
CMC
$7.22B
| $699K | 0.02% |
34,282
-254
| -0.7% | -$4.36K |
2017 Q4
10 quarters
|
|
613
Nuveen Credit Strategies Income Fund
JQC
$668M
| $696K | 0.02% |
118,275
-1,572
| -1% | -$9.27K |
2018 Q1
9 quarters
|
|
614
Avery Dennison
AVY
$13B
| $694K | 0.02% |
6,084
+528
| +10% | +$58K |
2017 Q3
11 quarters
|
|
615
O'Reilly Automotive
ORLY
$70.1B
| $693K | 0.02% |
24,660
+615
| +3% | +$16.1K |
2017 Q3
11 quarters
|
|
|
AIMT
616
DELISTED
Aimmune Therapeutics
AIMT
| $690K | 0.02% |
41,298
+1,033
| +3% | +$17.5K |
2019 Q3
3 quarters
|
|
617
ICU Medical
ICUI
$4.07B
| $686K | 0.02% |
3,724
-2,366
| -39% | -$470K |
2017 Q3
11 quarters
|
|
618
DELISTED
Cubic Corporation
CUB
| $686K | 0.02% |
14,277
-272
| -2% | -$11.1K |
2017 Q3
11 quarters
|
|
619
Invitation Homes
INVH
$15.7B
| $679K | 0.02% |
24,662
-4,087
| -14% | -$102K |
2017 Q4
10 quarters
|
|
620
AngioDynamics
ANGO
$465M
| $678K | 0.02% |
66,675
+15,938
| +31% | +$164K |
2019 Q2
4 quarters
|
|
621
EOG Resources
EOG
$80.9B
| $678K | 0.02% |
13,383
-48
| -0.4% | -$2.33K |
2016 Q4
14 quarters
|
|
622
Gencor Industries
GENC
$263M
| $678K | 0.02% |
53,611
-4,820
| -8% | -$55.7K |
2017 Q1
13 quarters
|
|
623
Bank OZK
OZK
$4.9B
| $677K | 0.02% |
28,856
+2,395
| +9% | +$51.4K |
2016 Q3
15 quarters
|
|
624
Saic
SAIC
$5.51B
| $676K | 0.02% |
8,707
+2,697
| +45% | +$221K |
2020 Q1
1 quarter
|
|
625
MasterCraft Boat Holdings
MCFT
$465M
| $675K | 0.02% |
35,417
-8,354
| -19% | -$105K |
2019 Q3
3 quarters
|
|
Similar funds
SCRM
FIM
GFPC
IC
I
MC
FTI
AWM
Brinker Capital's Q2 2020 Portfolio in Review
As of Q2 2020, Brinker Capital held 1,002 positions worth $3.13B, up 25% from $2.51B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Brinker Capital deployed $133M of net new capital in Q2 2020, opening 95 new positions and adding to 529 existing holdings. Its largest new stake was iShares 1-5 Year Investment Grade Corporate Bond ETF: 282,435 shares worth $15.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, down from 37% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Schwab Short-Term US Treasury ETF, an estimated $29.5M trimmed.
- Brinker Capital's largest Q2 2020 buy was iShares 1-5 Year Investment Grade Corporate Bond ETF: 282,435 shares worth $15.5M.
- Brinker Capital added most to Vanguard Short-Term Corporate Bond ETF in Q2 2020, an estimated $9.82M increase.
- Brinker Capital's biggest Q2 2020 reduction was Schwab Short-Term US Treasury ETF, cutting an estimated $29.5M.
- Brinker Capital fully exited iShares Intermediate Government/Credit Bond ETF in Q2 2020, selling an estimated $14.6M.
- Brinker Capital's ten largest holdings make up 23% of its $3.13B portfolio in Q2 2020.
- Brinker Capital opened 95 new positions and closed 72 in Q2 2020.
- Brinker Capital's portfolio value rose 25% quarter-over-quarter to $3.13B.
Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.